Determine the Effects of Prone Positioning and NO in COVID-19 ARDS by EIT
NCT ID: NCT05715762
Last Updated: 2023-02-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
20 participants
OBSERVATIONAL
2022-12-21
2023-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Determine the Effect of Prone Positioning in Adults With ARDS by Electrical Impedance Tomography
NCT04725227
Improvement of ARDS Ventilation-perfusion Matching by Prone Positioning Assessed by EIT
NCT05765760
Prone Position Assessed by 3D EIT
NCT07083973
Prone Position With Different Types of Cushions in Patients With ARDS
NCT06184490
Early PP Monitored by EIT in Patients With ARDS
NCT05822869
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The EIT assessment is performed in patients ventilated in supine position, supine position with NO inhalation for 1 hour, prone position for 1 hour, prone position for 2 hours with NO inhalation for 1 hour, prone position for 3 hours, prone position for 16 hours, re-supine position for 3 hours. Arterial blood gas (ABG) analysis results, ventilator parameters and hemodynamic parameters are also recorded at each time point.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Ventilation in supine position
Patients are ventilated in supine position.
No interventions assigned to this group
Ventilation in supine position and NO inhalation
Patients are ventilated in supine position with NO inhalation for 1 hour.
NO inhalation
NO inhalation at 20 ppm
Ventilation in prone position for 1 hour
Patients are ventilated in prone position for 1 hour.
prone postion
ventilation at prone positioning
Ventilation in prone position for 2 hours plus NO inhalation for 1 hour
Patients are ventilated in prone position for 1 hour followed by ventilation in prone position with NO inhalation for 1 hour.
prone postion
ventilation at prone positioning
NO inhalation
NO inhalation at 20 ppm
Ventilation in prone position for 3 hours
Patients are ventilated in prone position for 1 hour followed by ventilation in prone position with NO inhalation for 1 hour. Then they are ventilated in prone position alone for 1 hour.
prone postion
ventilation at prone positioning
Ventilation in prone position for 16 hours
Patients are ventilated in prone position for 1 hour followed by ventilation in prone position with NO inhalation for 1 hour. Then they are ventilated in prone position alone for 14 hours.
prone postion
ventilation at prone positioning
Ventilation in re-supine position for 3 hours
Patients are ventilated in supine position for 3 hours followed by ventilation in prone position for 16 hours.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
prone postion
ventilation at prone positioning
NO inhalation
NO inhalation at 20 ppm
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shanghai Zhongshan Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ming Zhong, PhD
Role: STUDY_CHAIR
Fudan University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Zhongshan Hospital, Fudan University
Shanghai, Shanghai Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Ming Zhong, PhD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
eit20221221
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.